惠博普(002554) - 2022 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2022 was CNY 341,834,655.45, representing a 38.49% increase compared to CNY 246,821,874.04 in the same period last year[4] - The net profit attributable to shareholders for Q1 2022 was CNY 11,246,194.17, a 50.78% increase from CNY 7,458,674.39 year-on-year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 10,813,538.81, a significant turnaround from a loss of CNY 9,095,220.56 in the previous year, marking a 218.89% increase[4] - Total operating revenue for Q1 2022 was CNY 341,834,655.45, an increase from CNY 246,821,874.04 in Q1 2021, representing a growth of approximately 38.4%[22] - Net profit for Q1 2022 reached CNY 10,596,602.71, compared to a net profit of CNY 7,834,109.45 in Q1 2021, reflecting a growth of approximately 35.7%[24] - The comprehensive income for Q1 2022 was CNY 8,868,707.34, compared to CNY 8,147,512.38 in Q1 2021, reflecting an increase of about 8.8%[24] Cash Flow - The company's cash flow from operating activities showed a net outflow of CNY 9,250,065.93, an improvement of 92.60% compared to a net outflow of CNY 125,016,564.50 in the same period last year[4] - Operating cash inflow totaled 546,469,051.49, up from 330,996,157.56 in the previous period, representing a 65% increase[25] - Net cash flow from operating activities improved to -9,250,065.93 from -125,016,564.50 year-over-year[25] - Cash inflow from investment activities increased by 198.70% to CNY 61,048,555.88, compared to CNY 20,437,810.79 in the same period last year[12] - Net cash flow from investment activities was -89,472,911.28, worsening from -7,979,036.41 year-over-year[27] - Financing cash inflow amounted to 176,500,000.00, significantly up from 24,931,350.00 in the previous period[27] - Net cash flow from financing activities improved to 141,108,529.87 from -142,237,295.17 year-over-year[27] - The ending balance of cash and cash equivalents increased to 419,898,720.11 from 326,839,451.11[27] Assets and Liabilities - Total assets at the end of Q1 2022 were CNY 3,775,349,721.31, a decrease of 1.35% from CNY 3,827,131,585.40 at the end of the previous year[5] - The company's total assets decreased to CNY 3,775,349,721.31 in Q1 2022 from CNY 3,827,131,585.40 in Q1 2021, a decline of about 1.4%[21] - Current liabilities totaled CNY 1,027,181,611.77 in Q1 2022, down from CNY 1,125,515,730.53 in Q1 2021, representing a decrease of approximately 8.7%[21] - The company's long-term borrowings increased to CNY 275,210,000.00 in Q1 2022 from CNY 237,800,000.00 in Q1 2021, an increase of about 15.8%[21] - The total liabilities decreased to CNY 1,386,756,257.08 in Q1 2022 from CNY 1,448,406,828.51 in Q1 2021, a decline of approximately 4.3%[21] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 58,076, with the largest shareholder holding 30.22% of the shares[13] - The company reported a total of 299,783,772 shares issued in a private placement to Changsha Water Industry Group Co., Ltd. in January 2021[15] - The top ten shareholders hold a significant portion of the company's shares, with Changsha Water Industry Group Co., Ltd. holding 107,275,951 shares[15] Investment and Projects - The company confirmed sales revenue of CNY 18,772.37 million from the Iraq project, with a total contract amount of CNY 2,809.37 million[16] - The company is currently fulfilling contracts with LUKOIL in Iraq, with confirmed sales revenue of CNY 17,933.81 million[17] - The total amount of accounts receivable from the Kazakhstan project is CNY 52,375.46 million, with cumulative confirmed sales revenue of CNY 52,847.15 million[17] - The company has ongoing projects in Ethiopia with a total contract amount of CNY 31,158.46 million, which has not yet commenced[16] - The company is actively engaged in various international projects, indicating a strategy of market expansion and diversification[16] Other Financial Metrics - The company's weighted average return on equity was 0.48%, an increase of 0.14% from 0.34% in the previous year[4] - Research and development expenses for Q1 2022 were CNY 14,189,900.07, compared to CNY 11,357,593.61 in Q1 2021, indicating an increase of approximately 24.3%[22] - Basic earnings per share increased to 0.0083 from 0.0055 year-over-year[25] Audit Information - The company did not undergo an audit for the first quarter report[28]